92 related articles for article (PubMed ID: 27385556)
1. Platelet abnormalities in a family with von Willebrand disease type 2B (V1316M) and association with bleeding score.
Guglielmone HA; Smith N; Minoldo S; Jarchum GD; White-Adams T; Di Paola J
Haemophilia; 2016 Sep; 22(5):e455-8. PubMed ID: 27385556
[No Abstract] [Full Text] [Related]
2. Relevance of platelet desialylation and thrombocytopenia in type 2B von Willebrand disease: preclinical and clinical evidence.
Dupont A; Soukaseum C; Cheptou M; Adam F; Nipoti T; Lourenco-Rodrigues MD; Legendre P; Proulle V; Rauch A; Kawecki C; Bryckaert M; Rosa JP; Paris C; Ternisien C; Boisseau P; Goudemand J; Borgel D; Lasne D; Maurice P; Lenting PJ; Denis CV; Susen S; Kauskot A
Haematologica; 2019 Dec; 104(12):2493-2500. PubMed ID: 30819911
[TBL] [Abstract][Full Text] [Related]
3. Protein kinase C signaling dysfunction in von Willebrand disease (p.V1316M) type 2B platelets.
Casari C; Paul DS; Susen S; Lavenu-Bombled C; Harroche A; Piatt R; Poe KO; Lee RH; Bryckaert M; Christophe OD; Lenting PJ; Denis CV; Bergmeier W
Blood Adv; 2018 Jun; 2(12):1417-1428. PubMed ID: 29925524
[TBL] [Abstract][Full Text] [Related]
4. Characterisation of the p.A1461D mutation causing von Willebrand disease type 2B with severe thrombocytopenia, circulating giant platelets, and defective α-granule secretion.
Langer F; Obser T; Oyen F; Spath B; Holstein K; Greinacher A; White JG; Budde U; Bokemeyer C; Schneppenheim R
Thromb Haemost; 2014 Apr; 111(4):777-9. PubMed ID: 24337418
[No Abstract] [Full Text] [Related]
5. The anti-von Willebrand factor aptamer ARC1779 increases von Willebrand factor levels and platelet counts in patients with type 2B von Willebrand disease.
Jilma-Stohlawetz P; Knöbl P; Gilbert JC; Jilma B
Thromb Haemost; 2012 Aug; 108(2):284-90. PubMed ID: 22740102
[TBL] [Abstract][Full Text] [Related]
6. Genotyping might help therapeutic decision-making in patients with von Willebrand disease type 2 B.
Rugeri L; Fretigny M; Dargaud Y; Nougier C; Vinciguerra C
Haemophilia; 2016 Sep; 22(5):e439-43. PubMed ID: 27353798
[No Abstract] [Full Text] [Related]
7. Use of a thrombopoietin receptor agonist in von Willebrand disease type 2B (p.V1316M) with severe thrombocytopenia and intracranial hemorrhage.
Espitia O; Ternisien C; Agard C; Boisseau P; Denis CV; Fouassier M
Platelets; 2017 Jul; 28(5):518-520. PubMed ID: 27885890
[TBL] [Abstract][Full Text] [Related]
8. A family having type 2B von Willebrand disease with an R1306W mutation: Severe thrombocytopenia leads to the normalization of high molecular weight multimers.
Ozeki M; Kunishima S; Kasahara K; Funato M; Teramoto T; Kaneko H; Fukao T; Kondo N
Thromb Res; 2010 Feb; 125(2):e17-22. PubMed ID: 19740526
[TBL] [Abstract][Full Text] [Related]
9. Prospective study of low-dose ristocetin-induced platelet aggregation to identify type 2B von Willebrand disease (VWD) and platelet-type VWD in children.
Frontroth JP; Hepner M; Sciuccati G; Feliú Torres A; Pieroni G; Bonduel M
Thromb Haemost; 2010 Dec; 104(6):1158-65. PubMed ID: 20941465
[TBL] [Abstract][Full Text] [Related]
10. 2B or not to be--the 45-year saga of the Montreal Platelet Syndrome.
Poon MC; Rand ML; Jackson SC
Thromb Haemost; 2010 Nov; 104(5):903-10. PubMed ID: 20838735
[TBL] [Abstract][Full Text] [Related]
11. Genetic variants of VWF gene in type 2 von Willebrand disease.
Freitas SDS; Rezende SM; de Oliveira LC; Prezotti ANL; Renni MS; Corsini CA; Amorim MVA; Matosinho CGR; Carvalho MRS; Chaves DG
Haemophilia; 2019 Mar; 25(2):e78-e85. PubMed ID: 30817071
[TBL] [Abstract][Full Text] [Related]
12. An update on type 2B von Willebrand disease.
Mikhail S; Aldin ES; Streiff M; Zeidan A
Expert Rev Hematol; 2014 Apr; 7(2):217-31. PubMed ID: 24521271
[TBL] [Abstract][Full Text] [Related]
13. [Epidural labor analgesia and parturient with type 2B von Willebrand disease].
Lagarrigue J; Richez B; Julliac B; Saltel L; Nurden P; Sztark F
Ann Fr Anesth Reanim; 2013 Jan; 32(1):56-9. PubMed ID: 23218955
[TBL] [Abstract][Full Text] [Related]
14. Platelet clump visible to the naked eye in type 2B von Willebrand disease.
Al-Samkari H
Blood; 2021 Dec; 138(25):2742. PubMed ID: 34940814
[No Abstract] [Full Text] [Related]
15. Acquired von Willebrand syndrome type 2A in a JAK2-positive essential thrombocythaemia-affected member of a large von Willebrand disease family with a novel autosomal dominant A1716P mutation.
Giannini S; Solimando M; Fierro T; Baronciani L; Federici AB; Gresele P
Thromb Haemost; 2011 May; 105(5):921-4. PubMed ID: 21359411
[No Abstract] [Full Text] [Related]
16. A randomised pilot trial of the anti-von Willebrand factor aptamer ARC1779 in patients with type 2b von Willebrand disease.
Jilma B; Paulinska P; Jilma-Stohlawetz P; Gilbert JC; Hutabarat R; Knöbl P
Thromb Haemost; 2010 Sep; 104(3):563-70. PubMed ID: 20589313
[TBL] [Abstract][Full Text] [Related]
17. A family having type 2B von Willebrand disease with a novel VWF p.R1308S mutation: Detection of characteristic platelet aggregates on peripheral blood smears as the key aspect of diagnosis.
Hatta K; Kunishima S; Suganuma H; Tanaka N; Ohkawa N; Shimizu T
Thromb Res; 2015 Oct; 136(4):813-7. PubMed ID: 26278967
[TBL] [Abstract][Full Text] [Related]
18. A first Taiwanese Chinese family of type 2B von Willebrand disease with R1306W mutation.
Shen MC; Lin JS; Lin DS; Hsu SC; Lin B
Thromb Res; 2003; 112(5-6):291-5. PubMed ID: 15041272
[TBL] [Abstract][Full Text] [Related]
19. Identification of a homozygous missense mutation (p.Cys379Gly) in the D1 domain of von Willebrand factor propeptide in a family with type 2A (IIC) von Willebrand disease.
Shigekiyo T; Udaka K; Sekimoto E; Shibata H; Ozaki S; Higuchi Y; Matsumoto M
Haemophilia; 2018 Nov; 24(6):e422-e425. PubMed ID: 30175488
[No Abstract] [Full Text] [Related]
20. Thrombocytopathy and type 2B von Willebrand disease.
Ware J
J Clin Invest; 2013 Dec; 123(12):5004-6. PubMed ID: 24270415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
